Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies.
作者信息
Gulei Diana, Tomuleasa Ciprian, Qian Liren, Bagacean Cristina, Croce Carlo M, Ghiaur Gabriel
机构信息
Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Department of Hematology, Ion Chiricuta Clinical Cancer Center, Cluj Napoca, Romania.
出版信息
Front Pharmacol. 2020 Dec 10;11:614614. doi: 10.3389/fphar.2020.614614. eCollection 2020.
Abstract
摘要
相似文献
1
Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies.社论：靶向造血系统恶性肿瘤微环境和表观遗传变化的新型药物
Front Pharmacol. 2020 Dec 10;11:614614. doi: 10.3389/fphar.2020.614614. eCollection 2020.
2
Genetic, epigenetic, and lineage-directed mechanisms in benzene-induced malignancies and hematotoxicity targeting hematopoietic stem cells niche.苯诱导的恶性肿瘤和血液毒性中针对造血干细胞龛的遗传、表观遗传和谱系定向机制。
Hum Exp Toxicol. 2020 May;39(5):577-595. doi: 10.1177/0960327119895570. Epub 2019 Dec 30.
3
Insights into novel emerging epigenetic drugs in myeloid malignancies.髓系恶性肿瘤新型表观遗传药物的研究进展
Ther Adv Hematol. 2019 Aug 6;10:2040620719866081. doi: 10.1177/2040620719866081. eCollection 2019.
4
Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies.血液系统恶性肿瘤的表观突变图谱作为新型表观遗传疗法的诱人靶点。
Oncotarget. 2016 Aug 30;7(35):57327-57350. doi: 10.18632/oncotarget.10033.
5
The role of the tumor microenvironment in hematological malignancies and implication for therapy.
Front Biosci. 2005 May 1;10:1581-96. doi: 10.2741/1642.
6
Epigenetic immunomodulation of hematopoietic malignancies.造血系统恶性肿瘤的表观遗传免疫调节
Semin Oncol. 2005 Oct;32(5):503-10. doi: 10.1053/j.seminoncol.2005.07.006.
7
Beyond genetics--the emerging role of epigenetic changes in hematopoietic malignancies.超越遗传学——表观遗传变化在血液系统恶性肿瘤中的新作用
Int J Hematol. 2004 Aug;80(2):120-7. doi: 10.1532/ijh97.04075.
8
[A primer for epigenetics of hematological malignancies].[血液系统恶性肿瘤表观遗传学入门]
Rinsho Ketsueki. 2016;57(10):1835-1844. doi: 10.11406/rinketsu.57.1835.
9
Role of epigenetic changes in hematological malignancies.表观遗传变化在血液系统恶性肿瘤中的作用。
Ann Hematol. 2004 Mar;83(3):137-52. doi: 10.1007/s00277-003-0798-7. Epub 2003 Dec 2.
10
Cancer associated fibroblasts in hematological malignancies.血液系统恶性肿瘤中的癌症相关成纤维细胞
Oncotarget. 2015 Feb 20;6(5):2589-603. doi: 10.18632/oncotarget.2661.
引用本文的文献
1
Extramedullary Hematopoiesis of the Liver and Spleen.肝脏和脾脏的髓外造血
J Clin Med. 2021 Dec 13;10(24):5831. doi: 10.3390/jcm10245831.
本文引用的文献
1
Targeting the Microenvironment in MDS: The Final Frontier.靶向骨髓增生异常综合征的微环境：最后的前沿领域。
Front Pharmacol. 2020 Jul 9;11:1044. doi: 10.3389/fphar.2020.01044. eCollection 2020.
2
SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?基于表面增强拉曼光谱的急性早幼粒细胞白血病微小残留病评估？
Front Oncol. 2020 Jun 29;10:1024. doi: 10.3389/fonc.2020.01024. eCollection 2020.
3
Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases.根据BFM ALL IC 2009方案治疗的急性淋巴细胞白血病患者第15天和第33天的微小残留病评估：133例单中心经验
Front Oncol. 2020 Jun 30;10:923. doi: 10.3389/fonc.2020.00923. eCollection 2020.
4
The Contribution of Epigenetics to Cancer Immunotherapy.表观遗传学在癌症免疫治疗中的贡献。
Trends Immunol. 2020 Aug;41(8):676-691. doi: 10.1016/j.it.2020.06.002. Epub 2020 Jul 2.
5
Cancer Epigenetics, Tumor Immunity, and Immunotherapy.癌症表观遗传学、肿瘤免疫与免疫治疗。
Trends Cancer. 2020 Jul;6(7):580-592. doi: 10.1016/j.trecan.2020.02.003. Epub 2020 Mar 31.
6
Single-Center Experience With Epigenetic Treatment for Juvenile Myelomonocytic Leukemia.青少年骨髓单核细胞白血病表观遗传治疗的单中心经验
Front Oncol. 2020 Apr 9;10:484. doi: 10.3389/fonc.2020.00484. eCollection 2020.
7
B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles.B7阳性和B7阴性急性髓系白血病表现出不同的T细胞成熟谱、免疫检查点受体表达及欧洲白血病网风险谱。
Front Oncol. 2020 Mar 13;10:264. doi: 10.3389/fonc.2020.00264. eCollection 2020.
8
Epigenetic mechanisms driving tumor supportive microenvironment differentiation and function: a role in cancer therapy?驱动肿瘤支持性微环境分化和功能的表观遗传机制：在癌症治疗中发挥作用？
Epigenomics. 2020 Jan;12(2):157-169. doi: 10.2217/epi-2019-0165. Epub 2019 Dec 18.
9
Updates on the hematologic tumor microenvironment and its therapeutic targeting.血液肿瘤微环境及其治疗靶点的研究进展。
Haematologica. 2019 Oct;104(10):1928-1934. doi: 10.3324/haematol.2018.195396. Epub 2019 Sep 12.
10
The role of mA RNA methylation in human cancer.mRNA 甲基化在人类癌症中的作用。
Mol Cancer. 2019 May 29;18(1):103. doi: 10.1186/s12943-019-1033-z.
Zotero 插件